Tweet
denovo assembly
explanation about denovo asembly
-
-
Assembling short reads to create full-length sequences . de-novo assemblies are orders of magnitude slower and more memory intensive than mapping assemblies. -
de novo is Latin, basically meaning "from new". So a de novo assembly is without knowing anything about the answer - compared to a reference guided assembly where you have a simple genome for guidance.Comment
-
I love that such an incomplete question (phrase) got two thoughtful responses.Comment
-
His/her ISP may be charging by the word to access the internet
Three posts (so far) by that user have less than 5 words each.
Originally posted by mgogol View PostComment
-
Ha ha, good call.
On biostars, somebody would have deleted or closed it. I suppose there's a place for both approaches.Comment
-
Proteomics platforms are evolving rapidly, with advances in mass spectrometry and affinity-based approaches expanding what researchers can detect and at what scale. As the field moves toward deeper proteome coverage and clinical applications, scientists face an increasingly complex landscape of tools. This article will explore how researchers are navigating these choices to find the right platform for their work.
The systematic characterization of the human proteome has... -
Genomics studies in neuroscience face a special challenge due to the brain’s complexity and scarcity of samples. Mapping changes in cell type and state using conventional next-generation sequencing methods remains challenging. Advances in technologies like single-cell sequencing, spatial transcriptomics, and long-read sequencing have opened the door to deeper studies of the brain and diseases like Alzheimer’s, amyotrophic lateral sclerosis (ALS), and schizophrenia.
...07-09-2026, 11:10 AM -
Cancer survival rates have significantly increased in the last few decades in the United States, reaching a combined 70% 5-year survival rate by 2021. Behind this number, there are years of research to find new therapies, drug targets, and early detection methods. But there is one core challenge that keeps slowing down these advances, and it’s about drug resistance.
There is no single reason why many patients don’t respond to treatment as expected. Cancer is...07-08-2026, 05:17 AM
Comment